Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

Impact · against what's priced in

Regeneron receives a significant immediate capital infusion and pipeline expansion that exceeds current growth expectations, while Sanofi secures a long-term immunology strategy. The deal is a positive catalyst for REGN as the market had not priced in new multi-billion dollar collaboration milestones to offset Eylea's decline.

REGN+0.40: Challenges what's priced in
The price assumes

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

What matters in this story

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

What matters in this story

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

How each ticker is affected

Connected tickers

Track these names every morning.

Walmart Stock Moves Higher: What's Happening?

Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?

BBNX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

What matters in this story

Next reads from the same story arc

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

What matters in this story

Next reads from the same story arc

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

How each ticker is affected

Connected tickers

Track these names every morning.

Walmart Stock Moves Higher: What's Happening?

Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?

BBNX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript